DaVita HealthCare Partners Inc (DVA)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 691,535 608,973 467,707 513,825 560,400 679,770 834,158 903,169 978,450 964,750 863,670 771,452 773,642 844,740 829,336 901,285 810,981 416,338 136,272 129,997
Total stockholders’ equity US$ in thousands 1,056,100 1,199,200 1,017,440 825,470 712,326 532,672 604,784 843,771 755,508 1,149,440 1,277,780 1,248,110 1,383,570 1,574,760 2,153,920 1,947,850 2,133,410 2,318,580 4,049,300 3,875,350
ROE 65.48% 50.78% 45.97% 62.25% 78.67% 127.62% 137.93% 107.04% 129.51% 83.93% 67.59% 61.81% 55.92% 53.64% 38.50% 46.27% 38.01% 17.96% 3.37% 3.35%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $691,535K ÷ $1,056,100K
= 65.48%

The return on equity (ROE) of DaVita Inc has shown fluctuating trends over the past eight quarters. In Q4 2023, the ROE stood at 65.48%, which is lower compared to the previous quarter's ROE of 50.78%. Despite this decrease, the company's ROE remains relatively strong, indicating that DaVita Inc is effectively utilizing shareholder equity to generate profits.

Looking back over the past two years, DaVita Inc's ROE has experienced significant variations. In Q3 2022 and Q2 2022, the company had exceptionally high ROE figures of 127.62% and 137.93% respectively, indicating strong profitability and efficient management of shareholder investments during that period. However, recent quarters have shown a downward trend in ROE, with Q2 2023 and Q1 2023 recording ROE figures of 45.97% and 62.25% respectively.

Overall, while DaVita Inc's ROE has experienced fluctuations, the company has demonstrated an ability to generate favorable returns for its shareholders. It will be important to monitor future financial performance to assess whether the recent downward trend in ROE is temporary or indicative of broader underlying challenges.


Peer comparison

Dec 31, 2023

Company name
Symbol
ROE
DaVita HealthCare Partners Inc
DVA
65.48%
Progyny Inc
PGNY
11.21%
Sotera Health Co
SHC
11.58%